These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 37636690
21. Normal tissue complication probability modeling of radiation-induced sensorineural hearing loss after head-and-neck radiation therapy. Cheraghi S, Nikoofar A, Bakhshandeh M, Khoei S, Farahani S, Abdollahi H, Mahdavi SR. Int J Radiat Biol; 2017 Dec; 93(12):1327-1333. PubMed ID: 28967273 [Abstract] [Full Text] [Related]
22. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer. Madasu R, Ruckenstein MJ, Leake F, Steere E, Robbins KT. Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):978-81. PubMed ID: 9305250 [Abstract] [Full Text] [Related]
23. Cochlea sparing effects of intensity modulated radiation therapy in head and neck cancers patients: a long-term follow-up study. Theunissen EA, Zuur CL, Yurda ML, van der Baan S, Kornman AF, de Boer JP, Balm AJ, Rasch CR, Dreschler WA. J Otolaryngol Head Neck Surg; 2014 Aug 06; 43(1):30. PubMed ID: 25095702 [Abstract] [Full Text] [Related]
24. Determinants of Cochlear Dysfunction in Chronic Otitis Media: Mucosal Disease. Philipose R, Varghese A, Kumar N, Varghese SS. Indian J Otolaryngol Head Neck Surg; 2023 Dec 06; 75(4):3733-3738. PubMed ID: 37974794 [Abstract] [Full Text] [Related]
25. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery. Baschnagel AM, Chen PY, Bojrab D, Pieper D, Kartush J, Didyuk O, Naumann IC, Maitz A, Grills IS. J Neurosurg; 2013 Mar 06; 118(3):571-8. PubMed ID: 23216466 [Abstract] [Full Text] [Related]
28. Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer. Burger AVM, Duinkerken CW, van Sluis KE, de Boer JP, Navran A, Lanting CP, Jóźwiak K, Dreschler WA, Balm AJM, Zuur CL. Eur Arch Otorhinolaryngol; 2024 Sep 06. PubMed ID: 39242413 [Abstract] [Full Text] [Related]
29. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK, Lee AW, Chow SK. Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1335-42. PubMed ID: 18922648 [Abstract] [Full Text] [Related]
35. Cisplatin ototoxicity: the importance of baseline audiometry. Nagy JL, Adelstein DJ, Newman CW, Rybicki LA, Rice TW, Lavertu P. Am J Clin Oncol; 1999 Jun 01; 22(3):305-8. PubMed ID: 10362343 [Abstract] [Full Text] [Related]
36. Sensorineural Hearing Loss after Treatment for Head and Neck Cancer: A Review of the Literature. Shorter P, Harden F, Owen R, Burmeister B, Foote M. J Med Imaging Radiat Sci; 2014 Sep 01; 45(3):316-322. PubMed ID: 31051984 [Abstract] [Full Text] [Related]
37. Clinical Predictors of Cisplatin Chemoradiation-Induced Ototoxicity in HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study. Lee JJ, Alamleh S, Zhan LJ, Hueniken K, Mahler MB, Billfalk-Kelly A, Davies J, Brown MC, Spreafico A, Huang SH, Hope A, Xu W, Goldstein DP, Liu G. J Otolaryngol Head Neck Surg; 2024 Sep 01; 53():19160216241248671. PubMed ID: 39056507 [Abstract] [Full Text] [Related]